CERo Therapeutics Holdings, Inc.
CERO
$0.09
$0.0113.64%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.61% | -87.54% | -55.37% | -13.92% | -62.90% |
| Total Depreciation and Amortization | -5.93% | -2.49% | 1.13% | 4.13% | 39.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 45.39% | 48.10% | -109.07% | -4,727.01% | -99.22% |
| Change in Net Operating Assets | 184.83% | 516.00% | 359.82% | 240.10% | -77.93% |
| Cash from Operations | -11.97% | -22.68% | -30.19% | -123.07% | -137.14% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 103.62% | -- | -- | -- | -107.41% |
| Total Debt Issued | -96.64% | -96.64% | -98.65% | -30.30% | -67.49% |
| Total Debt Repaid | 63.29% | -49.82% | -1,943.15% | -- | -576.46% |
| Issuance of Common Stock | 8.37% | 68.03% | 27.78% | 90,609.38% | 113,016.88% |
| Repurchase of Common Stock | 67.72% | 88.95% | -264,726.32% | -264,726.32% | 96.75% |
| Issuance of Preferred Stock | -69.50% | -84.31% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 519.94% | 12,219.71% | 4,229.85% | 4,229.85% | -24,510.53% |
| Cash from Financing | -2.33% | 33.58% | 66.90% | 2,301.22% | 108.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,314.69% | 70.00% | 135.72% | 115.55% | -100.26% |